News

Taking the leap for cancer research
Weyergang wants to make cancer treatment more effective

EU wants more Comprehensive Cancer Centres
By 2030, EU wants 90% of eligible patients to have access to Comprehensive Cancer Centres.

Learning from the Americans
Interview with Ole Dahlberg, CEO of Curida Diatec

More personalised breast cancer screening
Can a new genetic test improve breast cancer screening?

Meet our newest members
Get to know the latest additions to our cancer cluster better!

Klynger samarbeider om å styrke investor-arbeidet
Klyngene har en unik rolle i å øke private investeringer til norsk næringsliv.

A leading Norwegian oncology arena
Cancer Crosslinks 2023 attracted more than 300 on-site participants.

GU Ventures visited Oslo Cancer Cluster Incubator
New connections between Oslo and Gothenburg

Meet the speakers of Cancer Crosslinks 2023
Cancer Crosslinks 2023 will feature a number of renowned cancer researchers from across the globe.

Gold Label awarded to Oslo Cancer Cluster
The highest recognition a cluster can receive.

Health companies gained investors’ attention
Strong oncology presence at DNB conference.

10 highlights from Oslo Cancer Cluster 2022
Find out what we have been up to this last year!